Background Image
Table of Contents Table of Contents
Previous Page  1265 / 1266 Next Page
Information
Show Menu
Previous Page 1265 / 1266 Next Page
Page Background

•

H15 (Boswellia serrata): limited activity

•

Mannitol: restricted to particular situations for 24-72 h

•

Bevacizumab (Avastin): i.v. administration, expensive, not

approved for anti-edematous therapy

•

Corticorelin acetate: synthetic corticotropin-releasing factor

Can we avoid/replace steroids?